Filing Flows › Caris Life Sciences (CAI) › Free cash flow
Caris Life Sciences (CAI) free cash flow by quarter
Caris Life Sciences' free cash flow was $6.4M in Q2 2026 (second quarter 2026), -72% from Q1 2026. Over the last 5 quarters it ranged from $5.9M (Q2 2025) to $55.3M (Q3 2025).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $6.4M | -72% | +8% |
| Q1 2026 | $22.5M | -43% | — |
| Q4 2025 | $39.7M | -28% | — |
| Q3 2025 | $55.3M | +837% | — |
| Q2 2025 | $5.9M | — | — |
Q2 2026 at a glance
Caris Life Sciences, Q2 2026: revenue $264M (+45% year over year), operating margin 10.2%, net loss $637K, operating cash flow $28.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is Caris Life Sciences' free cash flow?
Caris Life Sciences' free cash flow was $6.4M in Q2 2026 (second quarter 2026), -72% from Q1 2026.
How has Caris Life Sciences' free cash flow changed?
Over the last 5 quarters it ranged from $5.9M (Q2 2025) to $55.3M (Q3 2025).